ARCHIVE

• Chugai Applies for Combination of Herceptin, Xeloda for Gastric Cancer in Japan
  March 29, 2010

• Only 12% of Free Coupons for Cervical Cancer Checkups Used
  March 29, 2010

• Bayer to Enhance Links between Diagnostic Imaging, Oncology BU
  March 29, 2010

• Actemra Applied for Additional Indication in the US
  March 29, 2010

• Olmesartan, Prasugrel to Drive Sales of Daiichi Sankyo to ¥1,150 Bil. in FY2012
  March 29, 2010

• Eli Lilly Japan's Sales Up 19% in 2009
  March 22, 2010

• Torii to Develop Sublingual Desensitization Therapy for Pollinosis
  March 22, 2010

• Mediceo to Cut Costs Taking Advantage of ALCs
  March 22, 2010

• Takara Bio Ties Up with Univ. of Pennsylvania for HIV Gene Therapy
  March 22, 2010

• Morimoto Proposes Shared Manufacturing Site in Shanghai
  March 22, 2010

• Pfizer Discontinues PIII Study of Figitumumab for Advanced NSCLC
  March 22, 2010

• Will the Era of DI Pharmacists Arrive?
  March 22, 2010

• VEGF Trap-Eye Improved Visual Acuity in Patients with DME: Bayer
  March 22, 2010

• Symbicort Ranked No. 1 on GP Market
  March 22, 2010

• WG to Be Created to Increase Self-Sufficiency Rate for Blood Products
  March 22, 2010

• Booz & Company Proposes New Contract Manufacturing Business Model
  March 22, 2010

• JMA Strongly Opposed to Promotion of “Integrated Medicine”
  March 22, 2010

• Ajinomoto Pharm. to Set Out in April
  March 22, 2010

• Vaccine-Related Societies to Create Consortium to Deal with Korosho
  March 22, 2010

• Korosho Completes Hearings of Dispensing Pharmacy Chain Operators
  March 22, 2010

ページ

• « 先頭
• ‹ Prev
• …
• 137
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• …
• Next ›
• 最終 »